Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-26

Clinical Trial Update: Bone Mineral Density (BMD) in HIV Infection [NA]

View source ↗

Summary

A terminated clinical trial at University Hospital Strasbourg investigated bone mineral density in HIV infection, focusing on osteopenia and osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Osteopenia, Osteoporosis | NA | Status: TERMINATED